Allergy Therapeutics

Allergy Therapeutics is a pharmaceutical company focused on the research and development of allergy treatments, specifically allergen-specific immunotherapies. The company offers both injectable and sublingual therapies for pollen-related allergies affecting grasses, weeds, and trees, as well as diagnostics. Its product portfolio includes Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Venomil, and peanut allergy treatments, among others. Allergy Therapeutics also develops vaccines targeting allergies to grass, trees, house dust mites, and peanuts. Operating primarily in Central and Southern Europe, as well as the United Kingdom, the company emphasizes providing solutions that address the underlying causes of allergies rather than just alleviating symptoms. Established in 2004, Allergy Therapeutics is headquartered in Worthing, United Kingdom.

Shaun Furlong

CFO

Martin Hopcroft

Interim CFO

Bodo Steinert

Managing Director

2 past transactions

Alerpharma

Acquisition in 2015
Alerpharma is develops and offers allergy immunotherapy products and services.

TEOMED

Acquisition in 2010
TEOMED AG distributes allergy vaccines, medicines, diagnostics, medical devices, and research reagents. The company was founded in 1989 and is based in Greifensee, Switzerland. As of July 1, 2010, TEOMED AG operates as a subsidiary of Allergy Therapeutics plc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.